Lecture 12: Pain and Opioid Analgesics Flashcards

1
Q

Definition of pain

A

Unpleasant sensory and emotional experience associated w real or potential tissue damage or described in terms of tissue damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 components of pain pathways

A
  • Peripheral nociceptive afferent neurons, which is activated by noxious stimuli
  • Central mechanisms by which afferent input generates a pain sensation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aδ fibers

A
  • Myelinated
  • 1-5μ diameter
  • Fast conductance (5-30m/s)
  • Fast localized rapid pain conduction
  • Activated by mechanosensitive and temperature sensitive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

C fibers

A
  • Unmyelinated
  • 0.1-1.5μm diameter
  • Slow conductance (<1m/s)
  • Mechanosensitive, temperature sensitive and chemical (capsaicin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can conduction in pain pathways be selectively blocked, and what makes Aδ fibers and C fibers prone to different types of interference?

A
  • Conduction in pain pathways can be selectively blocked.
  • Aδ fibers are prone to noxia, while C fibers are prone to being blocked by local anesthetics.
  • Knocking out both A and C fibers leads to the absence of pain, seen in certain developmental disorders.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why does the pain pathway have both fast (Adelta fibers) and slow (C fibers) components, and what is the functional significance of this distinction?

A
  • Both fibers release glutamate n neuropeptides
  • Fast pain, conducted by Adelta fibers, facilitates rapid withdrawal and helps limit tissue damage.
  • Slow pain, carried by C fibers, serves to immobilize the affected area, allowing time for healing and recovery.
  • Dual system provides an adaptive response to different types of noxious stimuli and contributes to the overall protective mechanisms of the body.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the pathway of the spinothalamic tract

A
  • Begins with sensory neurons located in the dorsal root ganglion (DRG), where pain fibers enter the dorsal horn of the spinal cord
  • From there, fibers ascend through the white matter of the spinal cord, reaching the thalamus where they synapse.
  • The signals are then relayed to the sensory cortex.
  • In the head, most pain fibers originate from the trigeminal nuclei, entering at the level of the brainstem.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the organization of the spinal cord and the role of lamina 2 in pain transmission

A
  • The spinal cord is organized into laminated layers.
  • Small afferent nerve fibers, which mainly carry pain signals, synapse into lamina II (AKA substantia gelatinosa)
  • This region is crucial in processing pain signals and is a target for analgesic medications aiming to alleviate pain. Additionally, pain signals can ascend segments of the spinal cord to cross over to the other side.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the gate theory of pain?

A
  • Mechanism in the spinal cord
  • Pain signals can be sent up to the brain to be processed to accentuate the possible perceived pain, or attenuate it at the spinal cord itself.
  • Gate: mechanism where pain signals can be let through or restricted.
  • If you activate other fibers that can prevent pain impulses from going into the brain
  • Distractive stimuli activates sensory fibers that carry the information into the brain
    • Activate inhibitory interneurons within the spinal cord, which acts to reduce the pain’s signal
  • Can only let certain sensations thru at one time
  • If you activate other sensory neurons, you prevent the pain from going thru the gap
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the descending pathway?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the periaqueductal gray (PAG) and its role in pain modulation?

A
  • PAG: region of cells surrounding the aqueduct in the midbrain, which is the central duct connecting the spinal cord to the brain
  • Stimulation of the PAG has been shown to produce inhibition of pain, effectively reducing the sensation of pain.
  • This region is involved in analgesic pathways, where it can modify how pain is felt.
  • By activating pathways that descend from the PAG, it is possible to inhibit pain signals, offering a potential mechanism for pain management and the action of certain analgesic drugs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are analgesics?

A
  • Local anesthetics: block nerve conduction
  • General anesthetics
  • Non-steroidal anti-inflammatory drugs (NSAIDS)
    • E.g. aspirin, ibuprofen
  • Opioids (morphine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are opiate analgesics (opioids)?

A
  • Potent analgesic
  • Opia: naturally occurring substance
  • Opioid: refers to both opiates n synthetic substances
  • Strict activity relationships [receptors]
  • Compounds are of similar structures
  • Morphines are archetypal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the CNS effects of opioids?

A
  • Profound anaglesia w/o loss of consciousness
    • Good for acute n chronic pain
    • Not so good for neuropathic pain (difficult to treat)
  • Respiratory depression
    • Reduce breathing by reducing sensitivity to PCO2
    • Causes to die w overdose
  • Nausea n vomiting
    • Activates chemotrigger zone (medulla)
    • Disappears w repeated administration (tolerance)
  • Euphoria, contentment and wellbeing
  • Dry mouth
  • Drowsiness/lethargy
  • Pholcodeine: depression of cough reflex
  • Pupillary constriction: stimulation of oculomotor nucleus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does an opioid drug affect sensitivity to carbon dioxide?

A
  • Opioid drugs can reduce sensitivity to carbon dioxide in the body.
  • Normally, carbon dioxide levels in the blood drive the breathing process.
  • However, opioids can shift the carbon dioxide response curve, making the body less sensitive to increases in carbon dioxide levels → stop breathing even when carbon dioxide levels rise, → respiratory depression.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Effect of opioids on the GI tract

A
  • Increases tone n reduces gut motility
  • Constipation
  • Delays gastric emptying → slows drug absorption
17
Q

What effect does opioid have on the direct release of histamine from mast cells?

A
  • Urticaria (hives)
  • Bronchoconstriction (bronchospam), hypotension
18
Q

How do opioid antagonists work?

A
  • Reverses the effect of opioid analgesics
  • Suggestion that there was a receptor is bc opioid effects are reversible w an antagonist/inactive derivative
  • Strict structure-activity relationships is consistent w receptors (unlike anesthetics)
    • Can predict the potency of the drug by their structures
    • GA has various structures
19
Q

How was the first opioid receptor discovered, and who conducted the study?

A
  • Found an opioid receptor thru ligand binding
    • Opiates labelled w radioisotopes n bound to brain membrane homogenates
  • Used 3H-levorphanol
  • Candace Pert n Solomon H. Snyder
    • Published first binding study of what would turn out to be the µ opioid receptor using 3H-naloxone
    • Derivatives of morphine
    • Found the binding curve
    • Can get specific binding to a receptor
    • CONCLUSION: first definitive evidence that there was a receptor for opioids in the brain (endogenous)
20
Q

How do opioid analgesics affect gut contractions?

A
  • Opioid analgesics (e.g. morphine) reduce gut contractions by acting on their receptors in the intestine.
  • This effect can be antagonized by naloxone, which blocks the action of opioids.
  • Studies have shown that different opioid analgesics have similar potencies in reducing gut contractions
    • Observed in both guinea pig ileum assays and human responses.
    • Methodology
      • Ground up the brain
      • Fractionated it
      • Tested the various fractions on his assay
      • 2 criteria: inhibit contractions like morphine AND reversible by naloxone
21
Q

Where are opioid peptides distributed in the brain and periphery?

A
  • Areas associated w nociception: PAG, rostral ventral medulla n substantia gelantosa
  • Enkephalins: diffuse distribution → suggests they play a role in many processes
  • β-endorphins: less diffuse distribution
    • Primarily found in the hypothalamus, which projects to the PAG and noradrenergic nuclei in the brain stem.
    • Also found in periphery in adrenal medulla, heart, kidney (unclear role)
22
Q

What is the role of endogenous opioid peptides?

A
  • Modulate pain perception
  • Reward
    • Do smtg good -> release enkephalins n endorphines
  • Stress response
  • Autonomic control
  • Activating opioid receptors
  • Opioid analgesics work thru the endogenous opioid system replacing or supplementing the endogenous ligands
23
Q

How do the effects of morphine and enkephalins differ in the guinea pig ileum and vas deferens?

A
  • Guinea pig ileum: morphine more effective than enkephalins in inhibiting contractions; this effect is blocked by naloxone
  • Vas deferens: enkephalins are more effective than morphine; effect is weakly blocked by naloxone.
24
Q

What does the observation of cross-tolerance and withdrawal symptoms suggest about opioid receptors?

A
  • Different opioid receptors may mediate distinct effects in different tissues
  • Indicates that opioid receptors are involved in various physiological processes and may have differential sensitivities to different opioid agonists.
25
Q

Distribution of opiate receptor, MOP

A
  • CNS n periphery
  • Cortex, thalamus, PAG, RVM, substantia gelantinosa
26
Q

Distribution of opiate receptor, KOP

A

Hypothalamus, PAG, substantia gelantinosa

27
Q

DOP

A

Pontine nuclei, amygdala, olfactory bulb, cortex

28
Q

Describe the cellular actions of opioid receptors

A
  • Opioid receptors are GPCRs
  • Upon activation, they inhibit calcium channels, activate potassium channels, and inhibit the production of cAMP
29
Q

How are opioid peptides stored and activated within cells?

A
  • Opioid peptides are initially stored as larger pro-molecules.
  • The active components are cleaved off from these precursor molecules.
    • Examples include proenkephalin and proopiomelanocortin.
30
Q

Mechanisms of Pain Modulation

A
  • Opioids exert their analgesic effects by activating descending inhibitory pathways that originate from the PAG region of the midbrain.
  • Activation of opioid receptors in the PAG leads to the release of endogenous opioid peptides, such as endorphins and enkephalins, which act on opioid receptors located on neurons in the rostral ventromedial medulla (RVM).
  • Neurons in the RVM send inhibitory projections to the dorsal horn of the spinal cord, where they inhibit the transmission of pain signals from primary afferent neurons.
31
Q

Tolerance

A
  • Increase in the dose required to produce a pharmacological effect
  • Occurs within a few days
  • Tolerance occurs to: analgesia, emesis, euphoria, respiratory depression
  • Addicts can take up to 50 times normal analgesic dose
  • No/little tolerance to constipation and pupil constriction
32
Q

Dependence

A
  • Craving that develops as a result of a repeated administration of the drug
  • Psychological dependence outlasts physical withdrawal symptoms
33
Q

Characteristics of Morphine Analogues

A
  • Half-life of 3-6 hours
  • Erratic absorption orally
  • Hepatic metabolism (conjugation with glucuronide). Some metabolites still active.
  • Most excreted in urine, a proportion via the gut (enterohepatic cycling)
  • Used on demand (infusion pump, PCA)
34
Q

Characteristics of Fentanyl

A
  • Acute pain and anesthesia
  • Patient-controlled infusion systems for chronic pain
  • Highly potent (about 100X morphine)
  • Rapid onset and short duration
  • Recently used to cut heroin and cocaine
  • Linked to many addict deaths (50,000 in USA, 2016)
35
Q

Characteristics of Codeine

A
  • Methyl ester of morphine
  • Naturally occurring in opium
  • Weaker analgesic than morphine (1/6 to 1/15 strength of morphine)
  • Less respiratory depression than morphine
  • Less liable to produce constipation
  • Often combined with paracetamol (co-codamol)
36
Q

Characteristics of Pethidine (Meperidine)

A
  • Short-lasting analgesia
  • Less potent than morphine
  • Anti-muscarinic effects (dry mouth, blurring of vision)
  • Duration similar to morphine
  • Less constipating than morphine
  • Analgesia during labor: does not reduce force of uterine contractions
  • Slow elimination in neonates may require naloxone (antagonist)
37
Q

Characteristics of Methadone

A
  • Used for chronic pain management and maintenance of addicts
  • Can be administered orally or via injection
  • Long half-life (greater than 24 hours)
  • Produces little euphoria and less sedation compared to morphine
  • Slow recovery attenuates withdrawal symptoms
  • Further information on addiction will be covered in a later lecture
38
Q

Opioid Antagonists: Nalorphine, Naloxone, Naltrexone

A
  • Competitive antagonists (except Nalorphine)
  • Useful for treating opioid overdose
  • Used to reverse respiratory depression in babies
  • Precipitate withdrawal symptoms in addicts (further information in later lectures)
39
Q

Buprenorphine (Temgesic)

A
  • Partial agonist at Mu Opioid Receptors (MOP)
  • Administration routes: Sublingual, injection, intrathecal
  • Inactive orally due to high first-pass metabolism
  • Half-life approximately 12 hours
  • Similar effects to morphine but with less respiratory depression
  • Useful for chronic pain and opioid dependence (in the USA)
  • Can precipitate withdrawal in patients dependent on morphine (further details in later addiction lectures)